NICE widens patient group for leukaemia drug.
Kmietowicz
Zosia
Z
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D004739:England; D017408:Guidelines as Topic; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D018579:Patient Selection; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate